loading

Day One Biopharmaceuticals Inc Stock (DAWN) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
12.18%
66.77
59.52 51.44 49.25 45.85
Operating Income/Loss
12.18%
-66.77
-59.52 -51.44 -49.25 -45.85
Income/Loss From Continuing Operations Before Tax
14.49%
-62.41
-54.51 -46.15 -45.86 -42.39
Income/Loss From Continuing Operations After Tax
14.49%
-62.41
-54.51 -46.15 -45.86 -42.39
Net Income/Loss
14.49%
-62.41
-54.51 -46.15 -45.86 -42.39
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
4,046%
86.68
2.0908 85.95 74.96 71.97
Diluted Average Shares
4,046%
86.68
2.0908 85.95 74.96 71.97
Basic Earnings Per Share
12.50%
-0.72
-0.64 -0.54 -0.61 -0.59
Diluted Earnings Per Share
12.50%
-0.72
-0.64 -0.54 -0.61 -0.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):